Search research articles
Contact Us
Filters
Showing results (341-350 of 353) with videos related to
Page
of 36
Sort By:
Nature Communications
|
August 29, 2020
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer
Jody Vykoukal, Johannes F Fahrmann, Justin R Gregg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer
Bo Liu, Likun Li, Guang Yang, et al.
European Journal of Epidemiology
|
January 4, 2024
Cohort profile: Beijing Healthy Aging Cohort Study (BHACS)
Miao Liu, Junhan Yang, Chunxiu Wang, et al.
Science China. Life Sciences
|
February 9, 2018
42,573 cases of hepatectomy in China: a multicenter retrospective investigation
Binhao Zhang, Bixiang Zhang, Zhiwei Zhang, et al.
Journal of Cancer Research and Therapeutics
|
June 1, 2020
CSCO ablation expert workshop report: Recommendations for the management of tumor ablation during the coronavirus disease 2019 epidemic
Yehua Shen, Chien-Shan Cheng, Peng Wang, et al.
Molecular Cancer Therapeutics
|
June 23, 2021
PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate Cancer
Cheng Wu, Shan Peng, Patrick G Pilié, et al.
International Journal of Surgery (London, England)
|
December 19, 2024
Laparoscopic hepatectomy versus microwave ablation for multifocal 3-5 cm hepatocellular carcinoma: a multi-centre, real-world study
Zhen Wang, Chuan Pang, Qiong Meng, et al.
International Journal of Surgery (London, England)
|
February 6, 2024
A multicenter case-controlled study on laparoscopic hepatectomy versus microwave ablation as first-line therapy for 3-5 cm hepatocellular carcinoma in patients aged 60 and older
Zhen Wang, Hua Zhang, Qiong Meng, et al.
Acta Pharmacologica Sinica
|
June 6, 2023
ATF4 renders human T-cell acute lymphoblastic leukemia cell resistance to FGFR1 inhibitors through amino acid metabolic reprogramming
Zi-Jian Zhang, Qi-Fang Wu, An-Qi Ren, et al.
Medical Image Analysis
|
October 22, 2020
PAIP 2019: Liver cancer segmentation challenge
Yoo Jung Kim, Hyungjoon Jang, Kyoungbun Lee, et al.
Page
of 36
Search research articles
Search
Showing results (341-350 of 353) with videos related to
Sort By:
Page
of 36
Nature Communications
|
August 29, 2020
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer
Jody Vykoukal, Johannes F Fahrmann, Justin R Gregg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer
Bo Liu, Likun Li, Guang Yang, et al.
European Journal of Epidemiology
|
January 4, 2024
Cohort profile: Beijing Healthy Aging Cohort Study (BHACS)
Miao Liu, Junhan Yang, Chunxiu Wang, et al.
Science China. Life Sciences
|
February 9, 2018
42,573 cases of hepatectomy in China: a multicenter retrospective investigation
Binhao Zhang, Bixiang Zhang, Zhiwei Zhang, et al.
Journal of Cancer Research and Therapeutics
|
June 1, 2020
CSCO ablation expert workshop report: Recommendations for the management of tumor ablation during the coronavirus disease 2019 epidemic
Yehua Shen, Chien-Shan Cheng, Peng Wang, et al.
Molecular Cancer Therapeutics
|
June 23, 2021
PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate Cancer
Cheng Wu, Shan Peng, Patrick G Pilié, et al.
International Journal of Surgery (London, England)
|
December 19, 2024
Laparoscopic hepatectomy versus microwave ablation for multifocal 3-5 cm hepatocellular carcinoma: a multi-centre, real-world study
Zhen Wang, Chuan Pang, Qiong Meng, et al.
International Journal of Surgery (London, England)
|
February 6, 2024
A multicenter case-controlled study on laparoscopic hepatectomy versus microwave ablation as first-line therapy for 3-5 cm hepatocellular carcinoma in patients aged 60 and older
Zhen Wang, Hua Zhang, Qiong Meng, et al.
Acta Pharmacologica Sinica
|
June 6, 2023
ATF4 renders human T-cell acute lymphoblastic leukemia cell resistance to FGFR1 inhibitors through amino acid metabolic reprogramming
Zi-Jian Zhang, Qi-Fang Wu, An-Qi Ren, et al.
Medical Image Analysis
|
October 22, 2020
PAIP 2019: Liver cancer segmentation challenge
Yoo Jung Kim, Hyungjoon Jang, Kyoungbun Lee, et al.
Page
of 36